Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavo

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
The Journal of Pediatrics|January 26, 2019
Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National SurveyMaría Rosa Pavo, Jaime de Inocencio
Casopis Lekaru Ceskych|February 4, 1999
[Selective estrogen receptor modulators as a new concept in preventing health risks of menopause]J Vokrouhlická, I Pavo, J Stĕpán
Journal of Perinatal Medicine|August 23, 2020
What is known and what remains unresolved regarding gestational diabetes mellitus (GDM)Katja Vince, Pavo Perković, Ratko Matijević
Psychiatria Danubina|October 2, 2008
Depression in dermatology: an integrative perspectivePavo Filaković, Darko Biljan, Anamarija Petek
Journal of Receptor Research|January 1, 1993
Lack of interaction of vasopressin with its antisense peptides: a functional and immunological studyM Jurzak, I Pavo, F Fahrenholz
Collegium Antropologicum|January 26, 2008
Psychoeducation and compliance in the treatment of patients with schizophreniaDunja Degmecić, Ivan Pozgain, Pavo Filaković
The New England Journal of Medicine|April 15, 2026
Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. ReplyStephen J Nicholls, Imre Pavo, David D'Alessio
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Effect of selective estrogen receptor modulators on estrogen-sensitive tissues]S Jirecek, I Pavo, J C Huber
Psychiatria Danubina|October 4, 2011
New strategies in the treatment of bipolar disorderPavo Filaković, Anamarija Petek Erić, Ivan Požgain
FEBS Letters|January 4, 1993
Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptorD A Jans, I Pavo, F Fahrenholz
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
The Journal of Pediatrics|January 26, 2019
Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National SurveyMaría Rosa Pavo, Jaime de Inocencio
Casopis Lekaru Ceskych|February 4, 1999
[Selective estrogen receptor modulators as a new concept in preventing health risks of menopause]J Vokrouhlická, I Pavo, J Stĕpán
Journal of Perinatal Medicine|August 23, 2020
What is known and what remains unresolved regarding gestational diabetes mellitus (GDM)Katja Vince, Pavo Perković, Ratko Matijević
Psychiatria Danubina|October 2, 2008
Depression in dermatology: an integrative perspectivePavo Filaković, Darko Biljan, Anamarija Petek
Journal of Receptor Research|January 1, 1993
Lack of interaction of vasopressin with its antisense peptides: a functional and immunological studyM Jurzak, I Pavo, F Fahrenholz
Collegium Antropologicum|January 26, 2008
Psychoeducation and compliance in the treatment of patients with schizophreniaDunja Degmecić, Ivan Pozgain, Pavo Filaković
The New England Journal of Medicine|April 15, 2026
Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. ReplyStephen J Nicholls, Imre Pavo, David D'Alessio
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Effect of selective estrogen receptor modulators on estrogen-sensitive tissues]S Jirecek, I Pavo, J C Huber
Psychiatria Danubina|October 4, 2011
New strategies in the treatment of bipolar disorderPavo Filaković, Anamarija Petek Erić, Ivan Požgain
FEBS Letters|January 4, 1993
Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptorD A Jans, I Pavo, F Fahrenholz
Pageof 33